Investigating health and education outcomes for adults and children with Achalasia
This study is led by Nandana Sreekala, Prof Katie Harron and Dr Conor McCann (UCL) and is funded by Mosawi Foundation through a PhD studentship.
This project was reviewed and approved through ECHILD's data access process. Learn how ECHILD data is kept safe.
-
We are trying to understand the population level burden of Achalasia in children and adults and how it affects the long-term health and educational outcomes of children.
-
Achalasia is a rare gastrointestinal motility disorder in which the lower oesophageal sphincter tightens due to loss of inhibitory motor neurons. This restricts the flow of liquids and solids into the stomach, leading to difficulties with swallowing, regurgitation and heartburn, which can significantly affect quality of life.
As little is known about the disease, this study will inform us about incidence, misdiagnosis pathways, and variation in care among patients affected by Achalasia in England. We will also investigate the long-term outcomes of children affected with Achalasia. This will help patients and clinicians understand whether early diagnostic interventions are needed and whether children need Special Educational Needs and Disabilities (SEND) provision.
-
We will use linked health and education records through ECHILD and identify people diagnosed with Achalasia with a specific code and map their healthcare journeys and long-term outcomes.
Find out more
-
Why does this matter?
Achalasia is a rare condition that affects the foodpipe, making it difficult for liquids and solids to pass from the mouth into the stomach. It happens when the muscle at the bottom of the food pipe does not relax properly. People with Achalasia can experience difficulty swallowing, bring food back, chest pain and weight loss. We know very little about how many people are affected in England, how they are treated, whether access to care is equal, or what happens to them in the long term.
What do we want to find out?
We want to find out how many children and adults in England have Achalasia, how they are diagnosed and treated, and whether access to healthcare differs across different groups of people and regions. We also want to understand how Achalasia affects children's health, education, and long-term outcomes.
What will we do?
We will use linked health and education data records from England to identify people with achalasia and follow their care over time.
We will investigate how often achalasia is mistaken for other conditions, such as acid reflux (GERD), and how long it takes for the correct diagnosis to be made. We will also investigate the treatments they receive, including surgery and other procedures, and whether these differ depending on where people live or their background. Because the actual disease causation is still unknown, we would like to explore patterns associated with autoimmune and viral factors, which are linked to the condition.
Finally, we will explore the long-term effects of Achalasia on children, including hospital readmissions, complications and mortality. By using linked data, we will also investigate whether children with Achalasia are more likely to need additional support at school.
-
Background and aims
Achalasia is a rare gastrointestinal disorder leading to impaired lower oesophageal sphincter relaxation and severe morbidity. Little is known about the population-level burden, treatment variation, inequality in access to care, or long-term outcomes across England. ECHILD will allow robust epidemiological profiling of Achalasia at scale.
This project aims to investigate population-based burden of Achalasia in terms of:
1. Epidemiology: Estimate national incidence and prevalence of Achalasia in children and adults from 1997–2024/25.
2. Service utilisation: Characterise diagnostic pathways, emergency presentations, outpatient follow-up, and intervention patterns (Heller myotomy, POEM, botulinum toxin).
3. Variation in care: Assess differences by region, deprivation, ethnicity, age group, and hospital type.
4. Long-term outcomes: Evaluate readmissions, complications, mortality and Special Educational Needs and Disability support at school.
Methods and analysis
We will use ECHILD to capture individuals diagnosed with Achalasia in England using ICD-10 code (K22).
Analyses will include:
• Time trend analysis of incidence/prevalence.
• Characterisation of diagnostic journeys, emergency presentations, outpatient attendance and treatment patterns.
• Multilevel modelling to assess variation by region and demographic factors.
• Estimation of survival rates, readmissions, and the proportion of children with recorded SEND provision by the end of secondary school (Year 11).
The study will use the following data sets from 1997 onwards: HES APC, HES OP, HES A&E, HES Critical Care, ONS Mortality. We will also use NPD data on Special Educational Needs Provision.
ECHILD data used:
HES: HES APC, HES OP, HES A&E, HES Critical Care, Mortality (1997 onwards)
NPD: Spring Census data from 2002 onwards.